These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2718233)

  • 1. A model to determine required pool size for HLA-typed community donor apheresis programs.
    Bolgiano DC; Larson EB; Slichter SJ
    Transfusion; 1989 May; 29(4):306-10. PubMed ID: 2718233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plateletapheresis program. II. Computer selection of HLA compatible donors.
    Jorgensen DW; McFarland JG; Hillman RS; Slichter SJ
    Transfusion; 1984; 24(4):292-8. PubMed ID: 6547791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-benefit analysis of a plateletapheresis program.
    McFarland JG; Larson EB; Hillman RS; Slichter SJ
    Transfusion; 1986; 26(1):91-7. PubMed ID: 3080832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selection of histocompatible apheresis platelet donors by cross-matching random donor platelet concentrates.
    O'Connell BA; Lee EJ; Rothko K; Hussein MA; Schiffer CA
    Blood; 1992 Jan; 79(2):527-31. PubMed ID: 1730095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategies to recruit plateletpheresis donors from a registry of HLA-typed, unrelated, bone marrow donors.
    Bolgiano DC; Smith S; Slichter SJ
    Transfusion; 1993 Aug; 33(8):675-8. PubMed ID: 8342236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicted effect of selectively testing female donors for HLA antibodies to mitigate transfusion-related acute lung injury risk from apheresis platelets.
    Eder AF; Dy BA; O'Neill EM
    Transfusion; 2016 Jun; 56(6 Pt 2):1608-15. PubMed ID: 26830063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effective cell support by repeat plateletpheresis of related donors on the IBM 2997 cell separator.
    Langley JW; Spiva D; Hendren D; Orrell J
    Am J Clin Pathol; 1981 Aug; 76(2):148-54. PubMed ID: 7270495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Size Estimation of HLA -Ⅰ class Typed Platelet Apheresis Donor Bank].
    Xue M; Pan QQ; Fan S; Wang XY; Zhao F; Liu TX; Shi LL; Ma L; Sheng J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Feb; 27(1):266-271. PubMed ID: 30738481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plateletapheresis program. I. Donor recruitment and commitment.
    Meyer DM; Hillman RS; Slichter SJ
    Transfusion; 1984; 24(4):287-91. PubMed ID: 6464150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of an appropriate size of unrelated donor pool to be registered for HLA-matched platelet transfusion.
    Takahashi K; Juji T; Miyazaki H
    Transfusion; 1987; 27(5):394-8. PubMed ID: 3477043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for HLA antibodies in plateletpheresis donors with a history of transfusion or pregnancy.
    De Clippel D; Baeten M; Torfs A; Emonds MP; Feys HB; Compernolle V; Vandekerckhove P
    Transfusion; 2014 Dec; 54(12):3036-42. PubMed ID: 24863861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Febrile reactions after platelet transfusion: the effect of single versus multiple donors.
    Chambers LA; Kruskall MS; Pacini DG; Donovan LM
    Transfusion; 1990; 30(3):219-21. PubMed ID: 1967118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Independent roles for platelet crossmatching and HLA in the selection of platelets for alloimmunized patients.
    Friedberg RC; Donnelly SF; Mintz PD
    Transfusion; 1994 Mar; 34(3):215-20. PubMed ID: 8146893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of a transfusion-related acute lung injury reduction strategy on apheresis platelet collections.
    Williams D; Rao M; Carey P
    J Clin Apher; 2012; 27(4):205-11. PubMed ID: 22535678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in hematological parameters post plateletpheresis: Single center study from North India.
    Rajput S; Makroo RN; Chowdhry M; Thakur UK
    Transfus Apher Sci; 2021 Dec; 60(6):103283. PubMed ID: 34625349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemoglobin and platelet count effect on platelet yields in plateletpheresis.
    Guerrero-Rivera S; Gutiérrez-Espíndola G; Talavera JO; Meillón-García LA; Pedraza-Echevarría M; Pizzuto-Chávez J
    Arch Med Res; 2003; 34(2):120-3. PubMed ID: 12700007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful removal of Chlamydia pneumoniae from plateletpheresis products collected using automated leukoreduction hemapheresis techniques.
    Webley W; Stuart E; Cirino F; Cahill F; Stec T; Andrzejewski C
    J Clin Apher; 2006 Oct; 21(3):195-201. PubMed ID: 16570261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The transfusion of HLA-matched platelets to thrombocytopenic patients resistant to random donor platelets.
    Levy L; Woodfield DG
    N Z Med J; 1984 Oct; 97(766):719-21. PubMed ID: 6595558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of donor factors contributing to plateletpheresis yields among apheresis platelet donors.
    Woodall WJ; Nguyen VQ; Tran MH
    J Clin Apher; 2014 Jun; 29(3):139-47. PubMed ID: 24222645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of random-donor platelet concentrates prepared from whole blood units and platelets prepared from single-donor apheresis collections.
    Sloand EM; Yu M; Klein HG
    Transfusion; 1996; 36(11-12):955-9. PubMed ID: 8937403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.